Posted On: 07/22/2014 8:06:11 AM
Post# of 1354
$PBIO rebound $0.379
O/S shares 13,596,594
10-Q 5/15/14
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
Initial Target of the Parabase Sequencing Service is the Neonatal Intensive Care Unit of U.S. Hospitals with the Goal of Improving Early Diagnosis of Genetic Diseases. Press Release
recent trades & PRs
Website
16% sell before Pr
O/S shares 13,596,594
10-Q 5/15/14
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
Initial Target of the Parabase Sequencing Service is the Neonatal Intensive Care Unit of U.S. Hospitals with the Goal of Improving Early Diagnosis of Genetic Diseases. Press Release
recent trades & PRs
Website
16% sell before Pr
(0)
(0)
